Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Apimeds Pharmaceuticals US Inc Stock Halal?
Shariah Compliance Analysis of APUS Stock
United States Health Care Nano Cap No. As of October 2026, Apimeds Pharmaceuticals US Inc (APUS) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Apimeds Pharmaceuticals US Inc does not pass Musaffa's business and financial screening criteria.
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
APUS Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Apimeds Pharmaceuticals US Inc is classified as not halal.
NOT HALALApimeds Pharmaceuticals US Inc (APUS) Chart
Fetching Price Chart...
Financial Metrics & Statements of Apimeds Pharmaceuticals US Inc (APUS)
FAQ's for Apimeds Pharmaceuticals US Inc (APUS)
- As of October 2026, Apimeds Pharmaceuticals US Inc APUS is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Apimeds Pharmaceuticals US Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Apimeds Pharmaceuticals US Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Apimeds Pharmaceuticals US Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Apimeds Pharmaceuticals US Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Apimeds Pharmaceuticals US Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Apimeds Pharmaceuticals US Inc (APUS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
